|
|
Article: GALILEO GENOMICS ANNOUNCES US DLRS 16.5-MILLION IN EQUITY FUNDING :: PR Newswire, London, October 10.
- Article from:
- PR Newswire
- Article date:
- October 10, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PR Newswire, London, October 10. This press release is transmitted on behalf of Galileo Genomics Inc.
Montreal - Galileo Genomics Inc., a Montreal-based genomics company, announced today it has secured $16.5-million in equity funding. The major investors participating in the funding are Investissement Desjardins of Canada, BTF of the Netherlands, MVI of Europe and HBM BioVentures of Switzerland.
Galileo will use these funds to search for genes associated with 25 common and economically important diseases. The research will be carried out with approximately 50,000 members of the Quebec population. The company will also use some of the equity funding to ...